NUE
36
2
WAT
59
-2
PNC
63
-2
ISRG
71
-2
CI
52
7
MDT
60
3
CFG
64
2
K
62
2
WDC
61
-2
ZBH
51
-2
VRSN
50
-8
LUV
59
-2
GD
53
3
EA
44
2
PVH
43
-2
GS
70
-2
INTC
15
-3
AAP
42
-2
KO
65
2
RSG
73
3
NUE
36
2
WAT
59
-2
PNC
63
-2
ISRG
71
-2
CI
52
7
MDT
60
3
CFG
64
2
K
62
2
WDC
61
-2
ZBH
51
-2
VRSN
50
-8
LUV
59
-2
GD
53
3
EA
44
2
PVH
43
-2
GS
70
-2
INTC
15
-3
AAP
42
-2
KO
65
2
RSG
73
3
Financhill
Sell
28

HBIO Quote, Financials, Valuation and Earnings

Last price:
$0.44
Seasonality move :
1.38%
Day range:
$0.43 - $0.58
52-week range:
$0.28 - $3.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.22x
P/B ratio:
1.39x
Volume:
13.6M
Avg. volume:
22.5M
1-year change:
-85.03%
Market cap:
$20.6M
Revenue:
$94.1M
EPS (TTM):
-$1.32

Harvard Bioscience SEC Filings

Company Filed Form Type Description
HBIO
Harvard Bioscience
 05/07/2024 10-Q 10-Q filing on 05/07/2024 View Form
HBIO
Harvard Bioscience
 11/07/2023 10-Q 10-Q filing on 11/07/2023 View Form
HBIO
Harvard Bioscience
 08/08/2023 10-Q 10-Q filing on 08/08/2023 View Form
HBIO
Harvard Bioscience
 04/26/2023 10-Q 10-Q filing on 04/26/2023 View Form
HBIO
Harvard Bioscience
 11/09/2022 10-Q 10-Q filing on 11/09/2022 View Form
HBIO
Harvard Bioscience
 08/04/2022 10-Q 10-Q filing on 08/04/2022 View Form
HBIO
Harvard Bioscience
 05/04/2022 10-Q 10-Q filing on 05/04/2022 View Form
HBIO
Harvard Bioscience
 11/05/2021 10-Q 10-Q filing on 11/05/2021 View Form
HBIO
Harvard Bioscience
 08/06/2021 10-Q 10-Q filing on 08/06/2021 View Form
HBIO
Harvard Bioscience
 05/07/2021 10-Q 10-Q filing on 05/07/2021 View Form
HBIO
Harvard Bioscience
 11/06/2020 10-Q 10-Q filing on 11/06/2020 View Form
HBIO
Harvard Bioscience
 08/10/2020 10-Q 10-Q filing on 08/10/2020 View Form
HBIO
Harvard Bioscience
 05/08/2020 10-Q 10-Q filing on 05/08/2020 View Form
HBIO
Harvard Bioscience
 03/16/2020 10-K 10-K filing on 03/16/2020 View Form
HBIO
Harvard Bioscience
 11/08/2019 10-Q 10-Q filing on 11/08/2019 View Form
HBIO
Harvard Bioscience
 08/08/2019 10-Q 10-Q filing on 08/08/2019 View Form
HBIO
Harvard Bioscience
 05/08/2019 10-Q 10-Q filing on 05/08/2019 View Form
HBIO
Harvard Bioscience
 03/18/2019 10-K 10-K filing on 03/18/2019 View Form
HBIO
Harvard Bioscience
 11/01/2018 10-Q 10-Q filing on 11/01/2018 View Form
HBIO
Harvard Bioscience
 08/02/2018 10-Q 10-Q filing on 08/02/2018 View Form
HBIO
Harvard Bioscience
 05/10/2018 10-Q 10-Q filing on 05/10/2018 View Form
HBIO
Harvard Bioscience
 03/16/2018 10-K 10-K filing on 03/16/2018 View Form
HBIO
Harvard Bioscience
 11/02/2017 10-Q 10-Q filing on 11/02/2017 View Form
HBIO
Harvard Bioscience
 08/03/2017 10-Q 10-Q filing on 08/03/2017 View Form
HBIO
Harvard Bioscience
 05/08/2017 10-Q 10-Q filing on 05/08/2017 View Form
HBIO
Harvard Bioscience
 03/17/2017 10-K 10-K filing on 03/17/2017 View Form
HBIO
Harvard Bioscience
 11/03/2016 10-Q 10-Q filing on 11/03/2016 View Form
HBIO
Harvard Bioscience
 08/04/2016 10-Q 10-Q filing on 08/04/2016 View Form
HBIO
Harvard Bioscience
 05/16/2016 10-Q 10-Q filing on 05/16/2016 View Form
HBIO
Harvard Bioscience
 04/29/2016 10-K 10-K filing on 04/29/2016 View Form
HBIO
Harvard Bioscience
 11/05/2015 10-Q 10-Q filing on 11/05/2015 View Form
HBIO
Harvard Bioscience
 08/06/2015 10-Q 10-Q filing on 08/06/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Free Training Webinar

Related Companies

Get HBIO Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

HBIO
Sector
P/E ratio
--
24.37x
PEG ratio
0.00x
0.00x
P/B ratio
1.39x
1.74x
Price / LTM sales
0.22x
1.65x

Growth Metrics

HBIO
Sector
Revenue growth
-11.17%
5.12%
Earnings growth
--
7.46%
Revenue (5-year growth)
-4.12%
8.25%
Earnings forecast
-$0.04
-$0.20

Profitability

HBIO
Sector
Profitability FY 2024
$54.8M
$51.2M
Return on invested capital
-62.88%
-14.95%
Return on assets
-48.4%
-12.07%
Return on equity
-103.83%
-17.16%

Earnings Date

Last Earnings Date
May
12
Next Earnings Date
Aug
8
Estimated Next Earnings Date
Aug
11

Balance Sheet

HBIO
Sector
Total cash
$5.5M
$38.3M
Short term investments
--
$33.2M
Total assets
$126.6M
$118.2M
Long term debt
$36M
$8.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Free Training Webinar

Popular

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Read article
Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Read article
Where Will Dell Stock Be in 5 Years?
Where Will Dell Stock Be in 5 Years?

So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…

Read article

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy or Sell?
Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Buy or Sell?
Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy or Sell?

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy or Sell?
Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Buy or Sell?
Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

Buy or Sell?
Master Safe Stock Market Strategies
Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas